Newgenivf Group Limited Stock Current Valuation
| NIVF Stock | 0.39 0.02 4.88% |
Valuation analysis of NewGenIvf Group helps investors to measure NewGenIvf Group's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The NewGenIvf Group's current Enterprise Value Over EBITDA is estimated to increase to 162.52. The NewGenIvf Group's current Enterprise Value Multiple is estimated to increase to 162.52. Fundamental drivers impacting NewGenIvf Group's valuation include:
Price Book 7.9127 | Enterprise Value 7.4 M | Enterprise Value Ebitda 19.1744 | Price Sales 1.3805 | Trailing PE 69.86 |
Overvalued
Today
Please note that NewGenIvf Group's price fluctuation is out of control at this time. Calculation of the real value of NewGenIvf Group is based on 3 months time horizon. Increasing NewGenIvf Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NewGenIvf stock is determined by what a typical buyer is willing to pay for full or partial control of NewGenIvf Group Limited. Since NewGenIvf Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NewGenIvf Stock. However, NewGenIvf Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.39 | Real 0.37 | Hype 0.43 | Naive 0.35 |
The real value of NewGenIvf Stock, also known as its intrinsic value, is the underlying worth of NewGenIvf Group Company, which is reflected in its stock price. It is based on NewGenIvf Group's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of NewGenIvf Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of NewGenIvf Group Limited helps investors to forecast how NewGenIvf stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NewGenIvf Group more accurately as focusing exclusively on NewGenIvf Group's fundamentals will not take into account other important factors: NewGenIvf Group Limited Company Current Valuation Analysis
NewGenIvf Group's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current NewGenIvf Group Current Valuation | 7.37 M |
Most of NewGenIvf Group's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NewGenIvf Group Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
NewGenIvf Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for NewGenIvf Group is extremely important. It helps to project a fair market value of NewGenIvf Stock properly, considering its historical fundamentals such as Current Valuation. Since NewGenIvf Group's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of NewGenIvf Group's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of NewGenIvf Group's interrelated accounts and indicators.
Click cells to compare fundamentals
NewGenIvf Current Valuation Historical Pattern
Today, most investors in NewGenIvf Group Stock are looking for potential investment opportunities by analyzing not only static indicators but also various NewGenIvf Group's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of NewGenIvf Group current valuation as a starting point in their analysis.
NewGenIvf Group Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, NewGenIvf Group Limited has a Current Valuation of 7.37 M. This is 99.95% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.96% higher than that of the company.
NewGenIvf Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NewGenIvf Group's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NewGenIvf Group could also be used in its relative valuation, which is a method of valuing NewGenIvf Group by comparing valuation metrics of similar companies.NewGenIvf Group is currently under evaluation in current valuation category among its peers.
NewGenIvf Fundamentals
| Current Valuation | 7.37 M | ||||
| Number Of Shares Shorted | 152.36 K | ||||
| Price To Book | 7.91 X | ||||
| Price To Sales | 1.38 X | ||||
| Revenue | 5.14 M | ||||
| EBITDA | (2.52 M) | ||||
| Net Income | (690.85 K) | ||||
| Total Debt | 1.62 M | ||||
| Cash Flow From Operations | (857.36 K) | ||||
| Market Capitalization | 7.09 M | ||||
| Total Asset | 21.32 M | ||||
| Retained Earnings | (5.67 M) | ||||
| Working Capital | 79 K | ||||
| Net Asset | 21.32 M |
About NewGenIvf Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NewGenIvf Group Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NewGenIvf Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NewGenIvf Group Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether NewGenIvf Group is a strong investment it is important to analyze NewGenIvf Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NewGenIvf Group's future performance. For an informed investment choice regarding NewGenIvf Stock, refer to the following important reports:Check out NewGenIvf Group Piotroski F Score and NewGenIvf Group Altman Z Score analysis. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewGenIvf Group. If investors know NewGenIvf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewGenIvf Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NewGenIvf Group is measured differently than its book value, which is the value of NewGenIvf that is recorded on the company's balance sheet. Investors also form their own opinion of NewGenIvf Group's value that differs from its market value or its book value, called intrinsic value, which is NewGenIvf Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewGenIvf Group's market value can be influenced by many factors that don't directly affect NewGenIvf Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewGenIvf Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewGenIvf Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewGenIvf Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.